| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |